Literature DB >> 1741934

Type I conceptus interferons: maternal recognition of pregnancy signals and potential therapeutic agents.

F W Bazer, H M Johnson.   

Abstract

In summary, Type I conceptus interferons of sheep, cows, and goats (perhaps all ruminants), which signal maternal recognition of pregnancy, may be useful for enhancing fertility in animal agriculture and may have a role in human and veterinary medicine as well. The Type I conceptus interferons share antiviral, anticellular, and immunosuppressive properties with Type I leukocyte interferons, but lack their cytotoxic effects, which may make them especially useful as therapeutic agents in human and veterinary medicine. The unique N-terminal structure of oTP-1 may account for its distinctive biological properties, including its antiluteolytic activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1741934     DOI: 10.1111/j.1600-0897.1991.tb00696.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  4 in total

1.  Oral administration of interferon tau enhances oxidation of energy substrates and reduces adiposity in Zucker diabetic fatty rats.

Authors:  Carmen D Tekwe; Jian Lei; Kang Yao; Reza Rezaei; Xilong Li; Sudath Dahanayaka; Raymond J Carroll; Cynthia J Meininger; Fuller W Bazer; Guoyao Wu
Journal:  Biofactors       Date:  2013-06-27       Impact factor: 6.113

2.  Functional multiple indicators, multiple causes measurement error models.

Authors:  Carmen D Tekwe; Roger S Zoh; Fuller W Bazer; Guoyao Wu; Raymond J Carroll
Journal:  Biometrics       Date:  2017-05-08       Impact factor: 2.571

3.  ISG15 expression in response to double-stranded RNA or LPS in cultured Fetal bovine lung (FBL) cells.

Authors:  C Liu; R Chang; X Yao; W T Qiao; Y Q Geng
Journal:  Vet Res Commun       Date:  2009-04-15       Impact factor: 2.459

Review 4.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.